全植入式助听系统:五年听力结果
这项前瞻性、非随机、多中心、自身对照研究纳入51例轻至重度感音神经性听力损失受试者,49例完成5年随访。与基线助听(BLA)条件相比,全植入式助听系统在每次年度随访中均改善言语接受阈值,5年时49%的受试者50 dB言语识别得分提高、41%保持不变,且报告了3例严重器械不良事件和15例器械不良事件。
要点
- 与基线助听条件相比,全植入式助听系统在每次年度随访中均改善言语接受阈值。
- 5年随访时,49%的受试者50 dB言语识别得分提高,41%保持不变。
- 研究期间报告3例严重器械不良事件(3例受试者)和15例器械不良事件(11例受试者)。
核心结论
- 全植入式助听系统在5年期间在所有测量领域均优于受试者的助听器,且被认为是安全的。
研究设计与样本
- 前瞻性、非随机、多中心、自身对照设计。
- 51例轻至重度感音神经性听力损失受试者于2008年至2009年植入,纳入上市后批准研究,设置包括私人诊所和医院。
- 49例受试者完成5年研究,包括年度随访。
- 主要有效性终点为言语接受阈值(SRT)和50 dB言语识别得分(WRS50)。
- 次要有效性终点为言语识别得分(WRS)和听力助益简表(APHAB)得分。
主要发现
- 与基线助听(BLA)条件相比,SRT得分在每次年度随访中均改善。
- 与BLA条件相比,5年随访时WRS50在49%的受试者中更好,在41%的受试者中相同。
- 与BLA条件相比,5年随访时WRS改善17%。
- 与BLA条件相比,APHAB得分在每次年度随访中大多数子量表均改善。
- 研究期间报告3例严重器械不良事件(3例受试者)和15例器械不良事件(11例受试者)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: 1) To provide long-term hearing outcome measures of a totally implantable hearing system (implant) and compare to the baseline unaided (BLU) and baseline aided (BLA) conditions, and 2) discuss relevant safety measures. STUDY DESIGN: Prospective, nonrandomized, multicenter, single-subject-as-own-control design. METHODS: Fifty-one subjects with mild to severe sensorineural hearing loss were implanted between 2008 and 2009 and enrolled in this postmarket approval study in the setting of private and hospital-based practices. Forty-nine of these subjects completed the 5-year study, which included annual follow-ups. Primary effectiveness endpoints were speech reception threshold (SRT) and word recognition scores at 50 dB (WRS50s). Secondary effectiveness endpoints were WRSs and the Abbreviated Profile of Hearing Aid Benefit (APHAB) scores. Adverse Device Effects (ADEs) and Serious Adverse Device Effects (SADEs) reported during the study period and a comparison of bone conduction scores are submitted as safety measures. RESULTS: Compared to the BLA condition, 1) SRT scores were improved at every annual follow-up; 2) WRS50s were better in 49%, and the same in 41% at the 5-year follow-up; 3) WRSs were improved by 17% at the 5-year follow-up; and 4) APHAB scores were improved in most subscales at every annual follow-up. There were three SADEs in three subjects and 15 ADEs in 11 subjects. Bone conduction scores increased by 3.7 dB at the 5-year follow-up. Average battery life was 4.9 years. CONCLUSIONS: The implant compared favorably to the subjects' hearing aid throughout the 5-year period in all of the areas measured and was found to be safe. LEVEL OF EVIDENCE: 2b. Laryngoscope, 128:210-216, 2018.
引用
- Shohet JA, Kraus EM, Catalano PJ, et al. Totally implantable hearing system: Five-year hearing results. Laryngoscope. 2017. PMID: 28407310. doi:10.1002/lary.26602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。